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Abstract
The use of cardiac pacemakers is increasing worldwide. Infective endocarditis from a pacemaker lead is a rare, but one of
the most severe complications of pacemaker insertion. The diagnosis of pacemaker-related infective endocarditis is usually
delayed due to unspeciﬁc clinical signs and symptoms at presentation compared to native valve infective endocarditis.
Several factors can increase the risk of cardiac pacemaker-related infective endocarditis including cachexia, malignancy,
diabetes mellitus, immunosuppression and corticosteroid treatment. This case report is about a 70-year-old diabetic male
who presented to the emergency department with disseminated intravascular coagulation (DIC), cardiac and liver failure.
He was diagnosed with pacemaker infective endocarditis, which was ultimately fatal.
CASE REPORT
History
A 70-year-old male presented to the Accident and Emergency
Department with a 3-day history of painless jaundice, pruritus,
non-productive cough and increasing shortness of breath with
an exercise tolerance limited to 50m. He also had diarrhoea,
unintentional weight loss and felt generally unwell and lethar-
gic. He denied any nausea, vomiting, urinary symptoms, chest
or abdominal pain. There was no history of recent travel.
His past medical history included a cerebrovascular accident
(5 years ago), Type 1 diabetes mellitus, ocular hypertension,
depression, previous alcohol excess (three bottles of whisky a
day for 8 years stopped 15 years ago (but no history of liver cir-
rhosis)) and a greater than 50 pack years smoking history. He
had a signiﬁcant cardiac history, suffering with angina, two
previous myocardial infarctions, a coronary artery bypass graft
and a biventricular pacemaker which was inserted in 2015.
Additionally, he also suffered from aortic stenosis, mitral regur-
gitation and moderate to severe left ventricular (LV) impair-
ment. His current medications included aspirin, spironolactone,
furosemide, carvedilol, candesartan, sildenaﬁl, clopidogrel, sim-
vastatin, citalopram and insulin.
On examination
He was alert and oriented, looked unkempt, had gynaecomastia,
proximal muscle wasting, was tanned but had no buccal pig-
mentation. He had a tattoo on his right arm. At rest he was apyr-
exial, respiratory rate of 18, O2 saturations of 95% on air. His
heart rate was 64 beats per minute (BPM), a normal jugular ven-
ous pressure and a capillary reﬁll time of 3 s. On chest
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examination, he had bibasal crepitations and a pan-systolic mur-
mur. His abdomen was distended with shifting dullness. There
were no signs of peritonitis, no masses, no organomegaly and
normal bowel sounds. There was no focal neurology. His lower
limbs had evidence of venous eczema with mild pitting oedema
and hyperpigmentation.
The following day the patient’s temperature fell to 35.5°C,
blood pressure dropped to 86/50, urine output dropped to
10ml/h and he became more confused.
Investigations
At presentation the patient’s electrocardiogram showed a ventricu-
lar paced rhythm with broad QRS complexes at 65BPM. Urine dip-
stick was negative. Two sets of blood cultures were negative
(patient did not have antibiotics prior to admission or prior to blood
cultures being taken). His initial blood tests are shown in Table 1.
Computed tomography (CT) revealed: biventricular cardiac
failure with reﬂux into inferior vena cava and hepatic veins,
bilateral pleural effusions, moderate abdominal ascites, fatty
liver, gallbladder sludge, but no stones or biliary tree dilatation,
normal kidneys with tiny simple cysts and enhancement of
both adrenal glands. No lymphadenopathy or masses.
Following the CT, a transthoracic echocardiogram was per-
formed. It showed a 5 × 5mm mobile echogenic lesion in the
right atrium associated with the LV pacing lead, 15mm from
the coronary sinus ostium (images in Fig. 1 and video 1). Other
ﬁndings included, severe impairment of LV systolic function
consistent with a previous myocardial infarction and an
endothelialised apical thrombus. While transoesophageal echo-
cardiogram would have been an ideal investigation, the patient
was deemed unﬁt for the procedure.
Differential diagnosis
Based on the history, blood analyses and the CT scan, a diagno-
sis of congestive heart failure with decompensated liver disease
and disseminated intravascular coagulation (DIC) was made. The
cause for the DIC was unclear. Malignancy (with liver involve-
ment) was suspected, however, no masses were identiﬁed on the
CT scan. Adrenal insufﬁciency (Addison’s disease) was one of
the top differentials on admission, so the patient was initially
treated with supportive therapy, dexamethasone and vitamin K
and kept for further investigations (shown in Table 2). A differen-
tial diagnosis of hepatorenal syndrome was considered; how-
ever, initial urea of 20.8 and Creatinine 135 together with low
LFTs (normal ALP, ALT 185 and Alb 32) was not indicative.
Table 1: Blood analyses on Days 1 and 5 post admission
Test Day1 Day 5 Reference range
C-reactive protein 24 20 <1mg/l
White cell count 8.6 16.4 3.6–11.0 × 109/l
Haemoglobin 178 166 130–180 g/L
Platelets count 24 46 140–400 × 109/L
Mean cell volume 86 80–100 ﬂ
Ferritin 486 25–350 ng/ml
INR 2.38 1.64
Activated partial
thromboplastin time
53 24–37 S
D-dimer 2147 <250 ng/ml
Fibrinogen 0.43 1.50–4.50 S
Sodium 122 129 135–145mmol/l
Potassium 4.8 4.8 3.5–5mmol/l
Urea 20.8 29.2 2.5–6.5mmol/l
Creatinine 135 227 55–120 µmol/l
Glucose 8.0 3.2–6.0mmol/l
Bilirubin 214 224 0–20 µmol/l
Alkaline phosphatase 106 85 20–140 U/l
Alanine transaminase 185 67 10–49 U/l
Albumin 32 26 32–48 g/l
Adjusted calcium 2.36 2.20–2.60mmol/l
Prostate speciﬁc antigen 1.3 0.1 to 4.0 ng/ml
Figure 1: Transthoracic echocardiography images. (A) A two chamber view,
long axis parasternal with posterolateral wall close to the LV lead. An echogenic
mobile mass is circled. (B) A short axis view showing dilated right atrium and
right ventricle with an echogenic mass circled. (C) An apical four chamber view,
pacing lead can be seen at the right atrium encircled with an echogenic mass
crossing the tricuspid valve. (D) A zoomed image C.
Table 2: Further investigations
Test Value Reference
range
Serum virology hepatitis A Negative
Serum virology hepatitis A Negative
Serum virology hepatitis A Negative
Serum virology hepatitis A Negative
Serum virology hepatitis A Negative
Serum virology hepatitis EBV Negative
Alpha-feto protein (TM) 3.5 0.0–10.0 kU/
Alpha 1 Antitrypsin 1.56 1.10–2.10 g/l
Caeruloplasmin 0.38 0.20–0.60 g/l
Anti-mitochondrial antibodies Negative
Anti-smooth muscle antibodies Negative
Anti-liver, kidney microsomal antibodies Negative
Anti-gastric parietal cell antibodies Negative
Anti-reticulin R1 Negative
Coombs test Negative
Blood cultures Negative
Sputum cultures Negative
Urine culture Negative
Faeces cryptosporidium Negative
Faeces Giardia Lamblia Negative
Faeces Escherichia coli 0157 Negative
Faeces Salmonella species Negative
Faeces Shigella species Negative
Faeces Campylobacter species Negative
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As the patient continued to deteriorate (hypothermia, low
systolic pressure and low urine output), a diagnosis of sepsis
causing DIC was made, which was narrowed to infective endo-
carditis based on echocardiogram results. Synacthen test and
ascitic tap were, therefore, not performed.
Treatment and Outcome
Once the diagnosis of sepsis was made, the patient was treated
with piperacillin–tazobactam, gentamicin and clarithromycin,
supported by pabrinex, sliding scale insulin, IV cryoprecipitate
and folate. Following echocardiogram ﬁndings, antibiotic ther-
apy was changed to ﬂucloxacillin and rifampicin and later
switched to teicoplanin. Ideally the patient would have been
transferred to a specialized cardiac unit for pacemaker extrac-
tion; however, given that the patient was haemodynamically
unstable this was not possible. The patient continued to deteri-
orate with refractory hypotension and low urine output, des-
pite active ﬂuid resuscitation. He continued to have persistent
hypothermia, desaturations and his blood tests showed wor-
sening kidney function. Given the patient’s poor prognosis a
discussion between the medical team, patient and the family
took place. A joint decision was reached that the patient was
not for any further escalation of treatment and that he should
not be resuscitated. Eight days later the patient died from
multi-organ failure caused by aggressive pacemaker sepsis
with associated DIC. Autopsy was not performed according to
family wishes.
DISCUSSION
Endocarditis associated with a pacemaker lead infection is a rare
but serious complication of pacemaker insertion [1]. The reported
incidence varies from 0.13 to 7% [2]. Medical treatment alone is
rarely successful, and current consensus is that the infected leads
should be removed urgently [3]. Several factors can increase the
risk of cardiac pacemaker-related infective endocarditis including
cachexia, malignancy, diabetes mellitus, immunosuppression
and corticosteroid treatment [4]. Staphylococci are involved in
the majority of these infections. The natural history of such infec-
tions is devastating, with a mortality rate of 33%. Recent evidence
suggests that the rate of infection seems to be rising [5], and
together with the increased use of cardiovascular implantable
electronic devices [6] this represents a new signiﬁcant clinical
challenge.
The presentation of such infections can be varied, including
non-speciﬁc signs and symptoms of systemic infection such as
fevers, chills, night sweats, malaise and anorexia. In up to 50%
of cases, blood culture results are negative for growth [7]. In
2013, Ward et al. [8] described a case of pacemaker-related bac-
terial endocarditis in a patient who presented to the local
emergency department with diarrhoea and productive sputum
and then rapidly progressed to DIC and death. Fewer than 10%
of patients present with septic shock. Patients may also pre-
sent with secondary foci, such as spinal or pulmonary infec-
tion [9]. Clinical diagnosis can, therefore, be challenging and is
often delayed.
It is crucial to suspect a diagnosis of endocarditis related
to pacemaker lead infection in the presence of fever, compli-
cations or pulmonary lesions in patients with permanent
pacemakers. Transoesophageal echocardiography should be
performed to look for vegetations [9]. One clinical study pro-
posed to use modiﬁed Dukes criteria for diagnosis of infective
endocarditis on pacemaker leads [7], and this has been
accepted by the recent British Society for Antimicrobial
Chemotherapy, British Heart Rhythm Society, British Cardio-
vascular Society, British Heart Valve Society and British Soci-
ety for Echocardiography joint guidelines [9]. The proposed
management includes early and total explantation of pacing
material and appropriate antibiotic therapy pursued for 6
weeks [10].
LEARNING POINTS
• Importance of including bacterial endocarditis in the early
differential diagnosis in patients with implanted pacemaker
devices presenting with signs of cardio/respiratory decline
even in the absence of sepsis or evidence of infection.
• Transoesophageal echocardiography should be performed for
diagnostic purposes.
• Management should be done according to the Duke’s criteria
and recent guidelines [9].
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Supplementary material is available at Oxford Medical Case
Reports online.
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